Micron Technology
MU
NVIDIA
NVDA
Intel
INTC
Adobe
ADBE
Salesforce
CRM
US Stock MarketDetailed Quotes
CNSP CNS Pharmaceuticals
- 0.1080
- -0.0020-1.82%
Close Dec 20 16:00 ET
- 0.1124
- +0.0044+4.07%
Post 20:01 ET
6.21MMarket Cap0.00P/E (TTM)
0.1200High0.1008Low4.81MVolume0.1050Open0.1100Pre Close528.01KTurnover8.52%Turnover Ratio0.00P/E (Static)57.49MShares70.000052wk High1.86P/B6.09MFloat Cap0.095552wk Low--Dividend TTM56.38MShs Float8534.8500Historical High--Div YieldTTM17.46%Amplitude0.0950Historical Low0.1090Avg Price1Lot Size
CNS Pharmaceuticals News
CNS Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
CNS Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
CNS Pharmaceuticals | 8-K: CNS Pharmaceuticals Reports First Quarter 2024 Financial Results Enrollment completed in potentially pivotal GBM study evaluating Berubicin; Topline data expected in first half of 2025
CNS Pharmaceuticals | 10-Q: Q1 2024 Earnings Report
CNS Pharmaceuticals | 10-K: FY2023 Annual Report
CNS Pharmaceuticals | 8-K: CNS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Reiterates Company is on Track to Achieve Milestones for Berubicin Potentially Pivotal Study Before Year End
CNS Pharmaceuticals | 10-Q: Q3 2023 Earnings Report
CNS Pharmaceuticals | 8-K: CNS Pharmaceuticals Reports Second Quarter 2023 Financial Results and Reiterates Upcoming Milestones
CNS Pharmaceuticals | 10-Q: Q2 2023 Earnings Report
CNS Pharmaceuticals | 8-K: CNS Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
CNS Pharmaceuticals | 10-Q: Q1 2023 Earnings Report
CNS Pharmaceuticals | 10-K/A: Annual report (Amendment)
CNS Pharmaceuticals | 10-K: FY2022 Annual Report
CNS Pharmaceuticals | 10-Q: Q3 2022 Earnings Report
CNS Pharmaceuticals | 8-K: CNS Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
CNS Pharmaceuticals | 10-Q: Q2 2022 Earnings Report
CNS Pharmaceuticals | 8-K: CNS Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
CNS Pharmaceuticals | 10-Q: Q1 2022 Earnings Report
CNS Pharmaceuticals | 10-K/A: Annual report (Amendment)
CNS Pharmaceuticals | 10-K: FY2021 Annual Report
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.